Combined with the findings on the DPP4i-BP–specific HLA affinity for the NC7-Col4 region of BP180, patients with DM and a genetic risk for producing anti-BP180 NC7-Col4 autoantibodies may develop BP via DPP4i intake. The gene discussed is COL17A1; the disease is diabetes mellitus.